Open access
97
Views
51
CrossRef citations to date
0
Altmetric
Original Research
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
Dave Singh1 Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester NHS Foundation Trust, Manchester, UKCorrespondence[email protected]
, M Reza Maleki-Yazdi2 Division of Respiratory Medicine, Women’s College Hospital, University of Toronto, ON, Canada
, Lee Tombs3 Precise Approach LTD, London UK
, Ahmar Iqbal4 Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA
, William A Fahy5 Respiratory Medicines Development Centre, GSK, Stockley Park, Middlesex, UK
& Ian Naya5 Respiratory Medicines Development Centre, GSK, Stockley Park, Middlesex, UK
Pages 1413-1424
|
Published online: 24 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.